The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.
PropertyValue
has major subject area list Antineoplastic Agents; Benzazepines; Bevacizumab; Brain Neoplasms; Glioma
information resource reference Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma. J Neurooncol. 2016 12; 130(3):571-579.
label Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.
Search Criteria
  • Glioma